Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Emerging Pandemic Threats program to combat newly emerging diseases of animal origin

The United States Agency for International Development (USAID) is launching an Emerging Pandemic Threats (EPT) program that builds on the successes of the Agency's long-standing programs in disease surveillance, training, and outbreak response, particularly those addressing avian and pandemic influenza.

22 Oct 2009

CDC urges heart disease patients get vaccinated against the flu each year

Cardiovascular disease was the leading cause of death in Florida in 2005, accounting for approximately 35 percent of all deaths in the state. People with heart disease are at a high risk for serious and potentially life-threatening complications from the flu.

22 Oct 2009

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

Millennium: The Takeda Oncology Company today announced the initiation of a Phase II clinical trial examining rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) with or without VELCADE® (bortezomib) for Injection for patients with a common type of lymphoma. The study will examine previously untreated patients with a genomically defined subtype of lymphoma called non-germinal center B-cell-like (non-GCB) diffuse large B-cell lymphoma.

22 Oct 2009

Women more likely than men to curb swine flu

A new American Red Cross poll shows that while concerns about exposure to the H1N1 (swine flu) virus remain high, women are more likely than men to make extra efforts to cover coughs and sneezes with tissue, wash their hands more carefully and use hand sanitizer more often.

22 Oct 2009

Northwest Biotherapeutics announces long-term data from Phase I and Phase I/II clinical trials of DCVax-Brain

Northwest Biotherapeutics, Inc. today announced further long-term follow-up data, for the period from January through September 2009, from its prior Phase I and Phase I/II clinical trials conducted at UCLA with DCVax®-Brain in patients with Glioblastoma multiforme ("GBM"). GBM is the most rapid and lethal type of brain cancer. During the update period, only one of the twenty patients treated with DCVax®-Brain (in addition to standard of care) died, and that patient had survived for nearly 7 years (80.5 months).

21 Oct 2009

Swine flu vaccines arrive at health departments, hospitals and community vaccinator facilities

The Swine Flu (H1N1)Vaccine is starting to arrive at health departments, hospitals, and community vaccinator facilities.

21 Oct 2009

MEDNET partners with Axius Healthcare Group to distribute MedSafe

What's the cost of saving a teenage life? When it comes to preventing accidental death resulting from prescription medication abuse, there's no price tag. Parents with good intentions, however, may be unaware that the lock-boxes they've installed are not protecting their teens from the ticking timebomb of prescription drugs.

21 Oct 2009

Novavax, Xcellerex enter into collaboration to accelerate the development of Novavax's 2009 H1N1 vaccine

Novavax, Inc. and Xcellerex, Inc. have entered into a strategic collaboration to accelerate the development of Novavax's vaccine manufacturing process to commercial scale and begin immediate production of Novavax's novel 2009 H1N1 influenza vaccine for potential commercial sale.

21 Oct 2009

Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus

Aethlon Medical, Inc. announced today that research studies have documented the Aethlon Hemopurifier® is effective in capturing the current pandemic strain of the H1N1 Swine Flu Virus. The Hemopurifier® is the first-in-class medical device able to selectively remove infectious viruses and immunosuppressive proteins from the bloodstream.

21 Oct 2009

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Bristol-Myers Squibb Company announced today that new clinical data support continued development of a subcutaneous administration of ORENCIA® (abatacept) for patients with moderate to severe rheumatoid arthritis.

21 Oct 2009

APHA urges Americans to be prepared for any kind of emergency

Setting the clocks on Nov. 1 because of daylight saving time gives us a little extra time to think about preparing for emergencies. Since Mother Nature is known to throw us a curveball when we least expect it, the American Public Health Association is urging Americans to be ready for any kind of emergency such as blizzards, floods, blackouts or influenza.

21 Oct 2009

MUSC launches Social Media Newsroom for real-time information on medical news and research

As the editorial landscape continues to evolve with the emergence of social media, many people struggle to find trusted resources that offer accurate, real time information related to healthcare news and research.

21 Oct 2009

Summit to highlight multi-system interoperability and transparency for safer US food supply chain

Colorado-based Traceability Institute announced today the dates of the first executive summit designed to initiate consensus to achieve multi-system interoperability with the goal of accomplishing a more sustainable and safer US food supply chain.

21 Oct 2009

Weekly Digest releases report on investment opportunities in connection with the H1N1 outbreak

Weekly Digest (http://www.bullmarket.com/digest), a free investment research publication, announced the publication of a special report on investment opportunities in connection with the H1N1 "Swine Flu" Outbreak, including updated outlooks for GlaxoSmithKline, Sanofi-Aventis, Novartis, Baxter International, Roche Holding and several others.

21 Oct 2009

New public health tool to identify all Tier 1 candidates for H1N1 vaccination

Practice Fusion Inc. (www.practicefusion.com), the free, web-based electronic health record (EHR) for physicians, today implemented a first-of-its-kind tool that allows its physician-users to immediately and accurately identify all Tier 1 candidates for H1N1 vaccination from their patient populations using criteria published by the Centers for Disease Control and Prevention (CDC).

21 Oct 2009

Drug abuse expert Dr. Drew Pinsky and the Five Moms join in fight against OTC cough medicine abuse

Dr. Drew Pinsky, a nationally renowned drug abuse expert, and the Five Moms, five exceptional women dedicated to spreading the word about the dangers of cough medicine abuse, are speaking out to educate parents and congressional staff on Capitol Hill about the issue of over-the-counter (OTC) cough medicine abuse among teens and how to prevent it through education.

21 Oct 2009

Swine flu treatments, safety issues prompt health workers to speak out

In anticipation of new swine flu cases, medical workers are looking for new ways help their patients - and protect themselves.

21 Oct 2009

CHA urges California Nurses Association to promote vaccinations to all health care workers

The California Hospital Association (CHA) is engaged with hospitals and state and local public health officials in a voluntary statewide effort to ensure that all hospital workers -- including registered nurses -- are vaccinated against the H1N1 flu virus.

21 Oct 2009

The medical homes model is spreading

A new model of health care called "medical homes" offers a stark contrast to hurried doctor visits, long waits and rushed physicians, the Chicago Tribune reports. Instead, a patients gets regular phone calls and e-mails from medical staff, reminders for flu screenings and vaccines, and less hurried doctors.

21 Oct 2009

Grady Memorial Hospital uses LiveProcess event log for emergency healthcare management

Facilities like Atlanta, Georgia-based Grady Memorial Hospital are taking extra precautions, including leveraging technology for emergency healthcare management, in anticipation of a H1N1 surge this fall.

21 Oct 2009

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Emerging Pandemic Threats program to combat newly emerging diseases of animal origin

CDC urges heart disease patients get vaccinated against the flu each year

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

Women more likely than men to curb swine flu

Northwest Biotherapeutics announces long-term data from Phase I and Phase I/II clinical trials of DCVax-Brain

Swine flu vaccines arrive at health departments, hospitals and community vaccinator facilities

MEDNET partners with Axius Healthcare Group to distribute MedSafe

Novavax, Xcellerex enter into collaboration to accelerate the development of Novavax's 2009 H1N1 vaccine

Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

APHA urges Americans to be prepared for any kind of emergency

MUSC launches Social Media Newsroom for real-time information on medical news and research

Summit to highlight multi-system interoperability and transparency for safer US food supply chain

Weekly Digest releases report on investment opportunities in connection with the H1N1 outbreak

New public health tool to identify all Tier 1 candidates for H1N1 vaccination

Drug abuse expert Dr. Drew Pinsky and the Five Moms join in fight against OTC cough medicine abuse

Swine flu treatments, safety issues prompt health workers to speak out

CHA urges California Nurses Association to promote vaccinations to all health care workers

The medical homes model is spreading

Grady Memorial Hospital uses LiveProcess event log for emergency healthcare management

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in